MADISON, Conn., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Vascular Insights LLC announced the start of a multi-centre randomized clinical trial conducted by principal investigators Professor of Vascular Surgery Alun H Davies and Consultant Vascular Surgeon Mr Ian J Franklin, Imperial College London and Imperial College Healthcare NHS Trust.
The Study hypothesis is that the ClariVein® procedure for varicose veins is potentially less painful than radiofrequency ablation (VNUS Closure Fast) under local anesthetic. This will be a multicentre randomized clinical trial with a group of 170 patients.
"This is great news for patients and clinicians who are searching for a quick and much less painful modality to heat based treatments for Venous reflux and of course varicose veins," said John P. Marano, President of Vascular Insights.
"Vascular Insights is committed to the best patient outcomes. We believe ClariVein®, as the newest and most innovative product on the market, delivers just that, the best outcomes. Its for that reason we continue to invest in having research conducted to quantify and qualify just how effective ClariVein® is," said Marano.
Professor Davies, principal investigator, said, "This study will evaluate two cutting edge technologies in the management of patients with varicose veins."
The ClariVein® catheter is a product of Vascular Insights LLC (http://vascularinsights.com) of Madison, Connecticut, USA. The company engages in the design, development, manufacture, and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease.
The investigators anticipate presenting initial data in early 2013.
The Vascular Insights LLC logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13814